BDMD · Baird Medical Investment Holdings Limited
United States · RS rating 4 · As of 2026-10-14
| Price | 0.55 USD |
|---|---|
| 1-day change | -19.6% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 3 / 5 / 10 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 17 / 3 / 16 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +84.0% |
| Market cap (USD) | $62.4M |